---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-008732"
form_type: "8-K"
ticker: "ACTU"
cik: "0001652935"
company_name: "ACTUATE THERAPEUTICS, INC."
filed_at: "2025-11-28T23:59:59+00:00"
generated_at: "2026-05-16T16:09:53.997352+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Actuate Therapeutics enters $100M ATM equity offering agreement with B. Riley and Craig-Hallum

## Summary
- Agreement allows sale of up to $100M of common stock through agents B. Riley Securities and Craig-Hallum Capital Group.
- Sales will be made under existing S-3 shelf registration; agents receive 3.0% commission on gross proceeds.
- Offers may be executed as at-the-market, privately negotiated, or block transactions at company's discretion.
- Company provides customary indemnification to the sales agents.

## SEC filing metadata
- accession: 0001683168-25-008732
- form_type: 8-K
- ticker: ACTU
- cik: 0001652935
- company_name: ACTUATE THERAPEUTICS, INC.
- filed_at: 2025-11-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/0001683168-25-008732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/actuate_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-008732
- JSON: https://secwatch.observer/filing/0001683168-25-008732.json
- Plain text: https://secwatch.observer/filing/0001683168-25-008732.txt

## Key facts
- Material Agreements
  ACTUATE THERAPEUTICS, INC. entered into At the Market Issuance Sales Agreement with B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC valued at aggregate offering price of up to $100,000,000 (effective 2025-11-28).
  - Action: entry
  - Agreement: atm program
  - Counterparty: B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC
  - Value: aggregate offering price of up to $100,000,000
  - Effective: 2025-11-28
  source text: On November 28, 2025, Actuate Therapeutics, Inc. (the “Company”) entered into an At the Market Issuance Sales Agreement (the “Agreement”) with B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC (each a “Sales Agent” and collectively the “Sales Agents”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, $0.000001 par value per share (“Common Stock”), to or through the Sales Agents, as its agents, having an aggregate offering price of up to $100,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1652935/000168316825008732/0001683168-25-008732-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.